| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2,500,000 | 84% | $16.00 | +$39,999,780 |
| Sells | 5 | -488,145 | 16% | $16.80 | -$8,201,028 |
| Net | -4 | +2,011,855 | 67% | +$31,798,752 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director, 10%+ Owner | $108,854,468 | +$39,999,780 | +58% | 26 Feb 2026 |
| Kiran Mazumdar-Shaw | Director, 10%+ Owner | $83,184,246 | 09 Jun 2025 | ||
| Biocon Ltd | 10%+ Owner | $73,155,178 | 16 Sep 2024 | ||
| TPG GP A, LLC | Former 10% Owner | $25,962,692 | 16 Sep 2024 | ||
| James E. Flynn | Possible Members of 10% Group, 10%+ Owner | $23,774,208 | 17 Sep 2024 | ||
| FMR LLC | Other* | $14,770,801 | 16 Sep 2024 | ||
| FIL Ltd | Other* | $13,426,861 | 16 Sep 2024 | ||
| Claire Mazumdar | Chief Executive Officer, Director | $6,363,871 | -$1,851,451 | -23% | 04 Mar 2026 |
| Ryan Cohlhepp | President and COO, Director | $3,725,996 | -$2,051,295 | -36% | 03 Mar 2026 |
| Ivan Hyep | Chief Financial Officer | $2,652,089 | -$1,514,829 | -36% | 03 Mar 2026 |
| David Raben | Chief Medical Officer | $1,024,045 | -$916,618 | -47% | 03 Mar 2026 |
| NILS LONBERG | Director | $397,183 | 09 Jun 2025 | ||
| Kate Haviland | Director | $98,491 | 09 Jun 2025 | ||
| Lara Meisner | Chief Legal Officer | $0 | -$1,866,836 | -100% | 02 Feb 2026 |
| Jake Simson | Director | 09 Jun 2025 | |||
| MICHAEL POWELL | Director | 09 Jun 2025 | |||
| Christopher Bowden | Director | 09 Jun 2025 | |||
| CAROLYN NG | Director | 12 Sep 2024 | |||
| Scott M. Robertson | Director | 09 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|